Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Cisplatin Should Not Replace Mitomycin in Treatment of Anal Canal Cancer
Link ID 5104
Title Cisplatin Should Not Replace Mitomycin in Treatment of Anal Canal Cancer
Url http://www.medscape.com/viewarticle/573353?src=rss
Description Results from a phase 3 trial showed no improvement in disease-free survival with cisplatin, and a significantly worse colostomy rate. Medscape Medical News
Category Articles > Hematology-Oncology
Keywords
Date Apr 23, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Hematology-Oncology
1. 2008 Gastrointestinal Cancers Symposium (GCS)
  Read clinically focused news coverage of key developments from the meeting.
Category:   Articles > Hematology-Oncology


2. Effect of Helicobacter pylori Eradication on Gastric Carcinogenesis
  Can the treatment of Helicobactor pylori decrease the incidence and severity of lesions with carcinogenic potential in patients with gastric carcinogenesis?
Laboratory Investigation
Category:   Articles > Hematology-Oncology


3. A Case of Vanishing Bile Duct Syndrome and IBD Secondary to Hodgkin’s Lymphoma
  Read more about this interesting case of 39-year-old man with abdominal pain, jaundice, diarrhea, weakness and weight loss.
Nature Clinical Practice Gastroenterology & Hepatology
Category:   Articles > Hematology-Oncology


4. Novel Drug Combinations for Advanced Breast Cancer
  In this Expert Interview from SABCS 2007, Dr. William J. Gradishar details the latest novel drug combinations that may benefit patients with advanced breast cancer.
Medscape Hematology-Oncology
Category:   Articles > Hematology-Oncology


5. Alpha1-Antitrypsin Deficiency Significantly Increases Risk for Lung Cancer
  Carriers of the alpha1-antitrypsin deficiency might have a risk of developing lung cancer that is up to 70% higher than that for noncarriers of the genetic defect. Medscape Medical News
Category:   Articles > Hematology-Oncology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS